Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

Best's Commentary: COVID-19 May Have Long-Term Implications on Trade Credit Insurance Market

The potential for increased insolvencies given the likelihood of a global recession amid the COVID-19 crisis, along with disruptions in complex global supply chains, are expected to lead to higher claims activity and pressure trade credit insurers' profitability, according to a new AM Best commentary.

A new Best's Commentary, titled, "Trade Credit Insurance: COVID-19 May Have Long-Term Implications," states that the short-tail nature of the trade credit product may partially offset the negative impacts, allowing for insurers to reprice and de-risk their portfolios, although incurred losses could be significant and involve costly litigation.

Depending on the level of insolvencies, and on the success of the mitigating actions taken by insurers, claims ratios could inch closer to the mid-to-high 80% levels seen during the financial crisis of 2008-2009 from the 45%-50% level achieved in the years after the crisis. AM Best expects trade credit insurance capacity to contract in the short term as insurers actively manage their risk exposures. Trade credit insurers can manage their exposures by setting specific conditions and credit levels or by reducing or withdrawing capacity to affected industries or geographies. Recent actions taken by governments and central banks will also help dampen the impact of the pandemic on trade credit insurers. Nonetheless, the potential impact on loss ratios remains subject to considerable uncertainty.

In the longer term, trade credit insurers will need to reconsider their pricing, limits, recovery rate assumptions and reinsurance strategies because of the pandemic. AM Best will continue to monitor the impact of the COVID-19 pandemic on the performance of its rated trade credit insurers.

To access the full copy of this commentary, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=295814.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

These press releases may also interest you

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As part of the "Stay in & SLING" initiative, SLING TV will stream Grand Ole Opry's 4,917th consecutive Saturday night concert with music legends Vince Gill and Amy Grant. The event is part of the SLING TV free experience, with no paid SLING TV...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...

News published on 27 march 2020 at 03:05 and distributed by: